SCHEMBL9764879

SCHEMBL9764879

CC(c1coc2ccccc12)(c1coc2ccccc12)N(O)CC(N)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.39
MAOB P27338 10/20 0.37
ALOX5 P09917 1/20 0.34
PSMB8 P28062 1/20 0.34
PSMB5 P28074 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA4 P22748 2/20 0.33
CA5A P35218 2/20 0.33
CA7 P43166 2/20 0.33
CA5B Q9Y2D0 2/20 0.33
GRK2 P25098 1/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
MAOA P21397 1/20 0.33
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9764908 0.82 MAOB (0.39) CA2MAOBALOX5GRK2MAPT
SCHEMBL9764896 0.81 MAOB (0.38) CA2MAOBALOX5GRK2MAPT
SCHEMBL10609848 0.78 MAOB (0.40) CA2MAOBPSMB8PSMB5KDM4C
SCHEMBL9764914 0.77 MAOB (0.40) CA2MAOBPSMB8PSMB5KDM4C
Ammonia Solution, Strong SCHEMBL9764887 0.76 MAOB (0.39) MAOBPSMB8PSMB5KDM4CMAPT
SCHEMBL9764903 0.76 MAOB (0.42) CA2MAOBPSMB8PSMB5KDM4C
SCHEMBL9764835 0.74 MAOB (0.41) CA2MAOBMAPTMAOAALDH1A1
SCHEMBL9764869 0.74 MAOB (0.37) CA2MAOBPSMB8PSMB5KDM4C
SCHEMBL10560471 0.74 MAOB (0.37) CA2MAOBPSMB8PSMB5KDM4C
SCHEMBL10595601 0.73 ALOX5 (0.45) CA2ALOX5CA1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0422079-A4 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE 1991-08-21 EP disclosed
EP-0422079-A1 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE ABBOTT LABORATORIES (US) 1991-04-17 EP disclosed
WO-1989012636-A1 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE ABBOTT LABORATORIES (US) 1989-12-28 WO disclosed
EP-0346939-A1 Tricyclic lipoxygenase inhibiting compounds ABBOTT LABORATORIES (US) 1989-12-20 EP disclosed
US-4822811-A Carbazole lipoxygenase inhibiting compounds, compositions and use ABBOTT LABORATORIES (US) 1989-04-18 US disclosed